CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-09 | FRIEDEMAN JESSICA Chief Marketing Officer | Sale | −15,000 | $3.61 | $54K | 205,000 |
| 2025-08-22 | FRIEDEMAN JESSICA Chief Marketing Officer | Grant or award | +50,000 | 220,000 | ||
| 2025-03-14 | FRIEDEMAN JESSICA Chief Marketing Officer | Sale | −30,000 | $5.66 | $170K | 170,000 |
| 2025-03-07 | FRIEDEMAN JESSICA Chief Marketing Officer | Grant or award | +50,000 | 200,000 | ||
| 2023-01-03 | FRIEDEMAN JESSICA Chief Marketing Officer | Grant or award | +150,000 | 150,000 |
Page 1 of 1 · 5 trades